Allison Casper, PA
Physician Assistant · Kearney, NENPI 1740502996
Payments from drug & device makers
Across 89 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$126
- Astellas Pharma US Inc$110
- Novartis$105
- AbbVie$73
- Blueprint Medicines Corporation$71
- Lilly USA, LLC$69
- plus $1K from 33 others
What the payments were for
- Food & beverage$1,51387%
- Education$22113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $126 |
| Astellas Pharma US Inc | 3 | $110 |
| Novartis | 7 | $105 |
| AbbVie | 3 | $73 |
| Blueprint Medicines Corporation | 3 | $71 |
| Lilly USA, LLC | 4 | $69 |
| Seagen Inc. | 4 | $62 |
| Incyte Corporation | 4 | $59 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $58 |
| Eisai Inc. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| E.r. Squibb & Sons, L.L.C. | 3 | $54 |
| Boehringer Ingelheim | 3 | $53 |
| Amgen | 3 | $47 |
| Merck | 3 | $46 |
| Johnson & Johnson(2 entities) | 3 | $46 |
| Teleflex LLC | 1 | $44 |
| Karyopharm Therapeutics Inc. | 2 | $43 |
| Acrotech Biopharma Inc. | 3 | $42 |
| Adaptive Biotechnologies Corporation | 2 | $39 |
| Myovant Sciences Inc. | 2 | $39 |
| Gilead(2 entities) | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 2 | $37 |
| Bristol Myers Squibb | 2 | $37 |
| AstraZeneca | 2 | $35 |
| GSK | 2 | $30 |
| Pfizer | 2 | $30 |
| Clovis Oncology, Inc. | 2 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Beigene USA, Inc. | 1 | $25 |
| EUSA Pharma (US) LLC | 1 | $24 |
| Servier Pharmaceuticals LLC | 1 | $24 |
| Coherus Oncology, Inc. | 1 | $20 |
| AVEO Pharmaceuticals, Inc. | 1 | $16 |
| Morphosys, US Inc. | 1 | $15 |
| Array Biopharma Inc | 1 | $14 |
| Myriad Genetic Laboratories, Inc. | 1 | $13 |
| Bayer | 1 | $12 |
| Sanofi | 1 | $12 |
How this compares
$1,734 in reported general payments places this provider in the 80th percentile of 1,127 physician assistant providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 17 | $1,202 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $444 |
| Dexamethasone | 38 | $388 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $332 |
| Acyclovir | 13 | $177 |
| Pantoprazole Sodium | 21 | $177 |
| Hydroxyurea | 13 | $131 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Kearney
- Kimberly GatesOmaha$109K
- Kandice DoleshOmaha$106K
- Ronda FoleyElkhorn$64K
- Kathryn KestiOmaha$34K
- Sarah GretemanOmaha$24K
- Joel JasaGrand Island$18K
- Christopher BeasleyOmaha$15K
- Laura TvrdyLincoln$13K
- Courtney MaresLincoln$13K
- Corrine GiggeeOmaha$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.